Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer.

作者： Ya-Chen Tina Shih , Linda S. Elting , Alexandre L. Pavluck , Andrew Stewart , Michael T. Halpern

关键词: Cancer 、 Internal medicine 、 Medicine 、 Initial treatment 、 Monoclonal antibody 、 Non-Hodgkin's lymphoma 、 Metastatic breast cancer 、 Immunotherapy 、 Outcomes research 、 Oncology 、 Colorectal cancer

摘要: ABSTRACTWe analyzed the utilization trend for immunotherapy as initial treatment in United States and estimated cost impact of three cancers which majority newly approved immunot...

参考文章(31)

RPh Claiborne E. Reeder, and Debra Gordon, Managing oncology costs. The American Journal of Managed Care. ,vol. 12, ,(2006)

C Richard, W Lockyer, DA Gillatt, BCG immunotherapy for superficial bladder cancer. Journal of the Royal Society of Medicine. ,vol. 94, pp. 119- 123 ,(2001) , 10.1177/014107680109400305

Camillo Porta, Chiara Paglino, Ilaria Imarisio, Lucia Bonomi, Cytokine-based immunotherapy for advanced kidney cancer: past results and future perspectives in the era of molecularly targeted agents. The Scientific World Journal. ,vol. 7, pp. 837- 849 ,(2007) , 10.1100/TSW.2007.154

B.J. Kennedy, Amy M. Fremgen, Herman R. Menck, The national cancer data base report on hodgkin's disease for 1985-1989 and 1990-1994 Cancer. ,vol. 83, pp. 1041- 1047 ,(1998) , 10.1002/(SICI)1097-0142(19980901)83:5<1041::AID-CNCR31>3.0.CO;2-5

Amy Y Chen, Michael T Halpern, Nicole M Schrag, Andrew Stewart, Marilyn Leitch, Elizabeth Ward, None, Disparities and Trends in Sentinel Lymph Node Biopsy Among Early-Stage Breast Cancer Patients (1998–2005) Journal of the National Cancer Institute. ,vol. 100, pp. 462- 474 ,(2008) , 10.1093/JNCI/DJN057

M. Stern, R. Herrmann, Overview of monoclonal antibodies in cancer therapy: present and promise Critical Reviews in Oncology Hematology. ,vol. 54, pp. 11- 29 ,(2005) , 10.1016/J.CRITREVONC.2004.10.011

Lisa C. Richardson, Lili Tian, Lydia Voti, Abraham G. Hartzema, Isildinha Reis, Lora E. Fleming, Jill MacKinnon, The Roles of Teaching Hospitals, Insurance Status, and Race/Ethnicity in Receipt of Adjuvant Therapy for Regional-Stage Breast Cancer in Florida American Journal of Public Health. ,vol. 96, pp. 160- 166 ,(2006) , 10.2105/AJPH.2004.053579

Janice M. Reichert, Viia E. Valge-Archer, Development trends for monoclonal antibody cancer therapeutics Nature Reviews Drug Discovery. ,vol. 6, pp. 349- 356 ,(2007) , 10.1038/NRD2241

John K. Iglehart, Biotech Drugs Come Of Age; Policymakers Take Notice Health Affairs. ,vol. 25, pp. 1202- 1203 ,(2006) , 10.1377/HLTHAFF.25.5.1202

10.

Michael T Halpern, John Bian, Elizabeth M Ward, Nicole M Schrag, Amy Y Chen, None, Insurance status and stage of cancer at diagnosis among women with breast cancer Cancer. ,vol. 110, pp. 403- 411 ,(2007) , 10.1002/CNCR.22786

Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer.

来源期刊

我的账户

Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer.

来源期刊

相似文章 10

我的账户